SNY
SANOFI SP ADR (SNY)
NASDAQ
$41.55-$0.23 (-0.56%)
Price as of Jun 23, 2026 2:07 PM EDT
  • $100.0B
    Market Cap
  • -8.48%
    1-Year Change
  • Drug Manufacturers - General
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
641.0M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
13.0B
-1.18%
13.2B
-7.24%
14.2B
+3.95%
13.7B
+11.75%
Gross Profit
33.7B
+8.32%
31.1B
-3.50%
32.2B
+1.62%
31.7B
+17.73%
Sales and Marketing Expense
9.5B
+3.92%
9.2B
-14.11%
10.7B
+1.91%
10.5B
+9.81%
Research and Development Expense
-7.8B
+6.06%
-7.4B
+9.90%
-6.7B
+0.33%
-6.7B
+17.81%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
9.5B
+3.92%
9.2B
-14.11%
10.7B
+1.91%
10.5B
+9.81%
Operating Profit
6.3B
-12.52%
7.3B
-7.91%
7.9B
-26.10%
10.7B
+31.13%
Interest Income
320.0M
-22.52%
413.0M
-22.51%
533.0M
+121.16%
241.0M
+346.30%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
320.0M
-22.52%
413.0M
-22.51%
533.0M
+121.16%
241.0M
+346.30%
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
7.9B
+39.75%
5.6B
+3.35%
5.4B
-35.93%
8.5B
+35.12%
Income Taxes
1.0B
-13.37%
1.2B
-24.84%
1.6B
-20.14%
2.0B
+28.75%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
7.9B
+39.75%
5.6B
+3.35%
5.4B
-35.93%
8.5B
+35.12%
Net Income from Continuing Operations Applicable to Common
7.9B
+39.75%
5.6B
+3.35%
5.4B
-35.93%
8.5B
+35.12%
Basic EPS and Net Income
6.40
+44.14%
4.44
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
6.37
+43.79%
4.43
N/A
N/A
N/A
N/A
N/A
Basic Weighted Average Shares
1.2B
-2.48%
1.3B
-0.02%
1.3B
-0.02%
1.3B
-0.05%
Diluted Weighted Average Shares
1.2B
-2.48%
1.3B
-0.02%
1.3B
-0.02%
1.3B
-0.05%
Balance Sheet
Cash and Cash Equivalents
7.7B
+2.90%
7.4B
-14.57%
8.7B
-31.61%
12.7B
+26.12%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
7.7B
+2.90%
7.4B
-14.57%
8.7B
-31.61%
12.7B
+26.12%
Total Current Assets
31.0B
-27.32%
42.6B
+2,814.99%
1.5B
+5.49%
1.4B
-79.80%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
10.1B
-0.39%
10.1B
-0.68%
10.2B
+2.95%
9.9B
-1.59%
Total Long-Term Assets
95.9B
+6.26%
90.2B
-5.83%
95.8B
+3.44%
92.6B
+3.37%
Total Assets
126.8B
-4.51%
132.8B
+5.01%
126.5B
-0.20%
126.7B
+5.39%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
28.3B
-2.80%
29.2B
N/A
N/A
N/A
N/A
N/A
Total Long-Term Debt
0
N/A
0
N/A
0
N/A
0
-100.00%
Total Long-Term Liabilities
26.8B
+3.77%
25.8B
-7.62%
27.9B
+1.12%
27.6B
-7.76%
Total Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Retained Earnings
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Stockholders Equity
71.7B
-7.90%
77.9B
+4.71%
74.4B
-1.06%
75.2B
+8.87%
Total Shares Outstanding
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
10.8B
+18.38%
9.1B
-11.47%
10.3B
-2.55%
10.5B
+0.04%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-2.4B
-44.47%
-4.4B
-28.92%
-6.2B
+198.80%
-2.1B
-71.57%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-8.2B
+42.41%
-5.8B
-28.43%
-8.1B
+38.33%
-5.8B
-17.50%
Financials Ratio
Gross Margin
-1,935.73%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
989.70%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
6.05%
+39.57%
4.33%
+0.92%
4.29%
-37.50%
6.87%
+28.45%
Return on Equity
10.50%
+42.22%
7.38%
+1.51%
7.27%
-38.21%
11.77%
+23.87%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.09
-25.23%
1.46
N/A
N/A
N/A
N/A
N/A
Cash Ratio
0.27
+5.84%
0.26
N/A
N/A
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow